Deep vein thrombosis: Current status and nanotechnology advances

Aniket S. Wadajkar, Sonia Santimano, Maham Rahimi, Baohong Yuan, Subhash Banerjee, Kytai T. Nguyen

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Deep vein thrombosis (DVT) affects up to 2 million people in the United States, and worldwide incidence is 70 to 113 cases per 100,000 per year. Mortality from DVT is often due to subsequent pulmonary embolism (PE). Precise diagnosis and treatment is thereby essential for the management of DVT. DVT is diagnosed by a thorough history and physical examination followed by laboratory and diagnostic tests. The choice of laboratory and diagnostic test is dependent on clinical pretest probability. Available laboratory and diagnostic techniques mainly involve D-dimer test, ultrasound, venography, and magnetic resonance imaging. The latter two diagnostic tools require high doses of contrast agents including either radioactive or toxic materials. The available treatment options include lifestyle modifications, mechanical compression, anticoagulant therapy, inferior vena cava filter, and thrombolysis/thrombolectomy. All of these medical and surgical treatments have serious side effects including improper clot clearance and increased risk of hemorrhage occurrence. Therefore, research in this field has recently focused on the development of non-invasive and accurate diagnostics, such as ultrasound enhanced techniques and molecular imaging methods, to assess thrombus location and its treatment course. The frontier of nanomedicine also shows high prospects in tackling DVT with efficient targeted drug delivery. This review describes the pathology of DVT along with successive medical problems such as PE and features a detailed listing of various diagnostic and therapeutic modalities that have been in use and are under development.

Original languageEnglish (US)
Pages (from-to)504-513
Number of pages10
JournalBiotechnology Advances
Volume31
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Nanotechnology
Venous Thrombosis
Ultrasonics
Medical nanotechnology
Toxic materials
Molecular imaging
Radioactive materials
Pathology
Magnetic resonance
Medical problems
Pulmonary Embolism
Routine Diagnostic Tests
Dimers
Anticoagulants
Contrast Media
Nanomedicine
Vena Cava Filters
Imaging techniques
Molecular Imaging
Phlebography

Keywords

  • Embolism
  • Fibrin clot
  • Nanoparticles
  • Thrombosis

ASJC Scopus subject areas

  • Biotechnology

Cite this

Deep vein thrombosis : Current status and nanotechnology advances. / Wadajkar, Aniket S.; Santimano, Sonia; Rahimi, Maham; Yuan, Baohong; Banerjee, Subhash; Nguyen, Kytai T.

In: Biotechnology Advances, Vol. 31, No. 5, 09.2013, p. 504-513.

Research output: Contribution to journalArticle

Wadajkar, AS, Santimano, S, Rahimi, M, Yuan, B, Banerjee, S & Nguyen, KT 2013, 'Deep vein thrombosis: Current status and nanotechnology advances', Biotechnology Advances, vol. 31, no. 5, pp. 504-513. https://doi.org/10.1016/j.biotechadv.2012.08.004
Wadajkar, Aniket S. ; Santimano, Sonia ; Rahimi, Maham ; Yuan, Baohong ; Banerjee, Subhash ; Nguyen, Kytai T. / Deep vein thrombosis : Current status and nanotechnology advances. In: Biotechnology Advances. 2013 ; Vol. 31, No. 5. pp. 504-513.
@article{fd015bde598040379466a3af6faefe79,
title = "Deep vein thrombosis: Current status and nanotechnology advances",
abstract = "Deep vein thrombosis (DVT) affects up to 2 million people in the United States, and worldwide incidence is 70 to 113 cases per 100,000 per year. Mortality from DVT is often due to subsequent pulmonary embolism (PE). Precise diagnosis and treatment is thereby essential for the management of DVT. DVT is diagnosed by a thorough history and physical examination followed by laboratory and diagnostic tests. The choice of laboratory and diagnostic test is dependent on clinical pretest probability. Available laboratory and diagnostic techniques mainly involve D-dimer test, ultrasound, venography, and magnetic resonance imaging. The latter two diagnostic tools require high doses of contrast agents including either radioactive or toxic materials. The available treatment options include lifestyle modifications, mechanical compression, anticoagulant therapy, inferior vena cava filter, and thrombolysis/thrombolectomy. All of these medical and surgical treatments have serious side effects including improper clot clearance and increased risk of hemorrhage occurrence. Therefore, research in this field has recently focused on the development of non-invasive and accurate diagnostics, such as ultrasound enhanced techniques and molecular imaging methods, to assess thrombus location and its treatment course. The frontier of nanomedicine also shows high prospects in tackling DVT with efficient targeted drug delivery. This review describes the pathology of DVT along with successive medical problems such as PE and features a detailed listing of various diagnostic and therapeutic modalities that have been in use and are under development.",
keywords = "Embolism, Fibrin clot, Nanoparticles, Thrombosis",
author = "Wadajkar, {Aniket S.} and Sonia Santimano and Maham Rahimi and Baohong Yuan and Subhash Banerjee and Nguyen, {Kytai T.}",
year = "2013",
month = "9",
doi = "10.1016/j.biotechadv.2012.08.004",
language = "English (US)",
volume = "31",
pages = "504--513",
journal = "Biotechnology Advances",
issn = "0734-9750",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Deep vein thrombosis

T2 - Current status and nanotechnology advances

AU - Wadajkar, Aniket S.

AU - Santimano, Sonia

AU - Rahimi, Maham

AU - Yuan, Baohong

AU - Banerjee, Subhash

AU - Nguyen, Kytai T.

PY - 2013/9

Y1 - 2013/9

N2 - Deep vein thrombosis (DVT) affects up to 2 million people in the United States, and worldwide incidence is 70 to 113 cases per 100,000 per year. Mortality from DVT is often due to subsequent pulmonary embolism (PE). Precise diagnosis and treatment is thereby essential for the management of DVT. DVT is diagnosed by a thorough history and physical examination followed by laboratory and diagnostic tests. The choice of laboratory and diagnostic test is dependent on clinical pretest probability. Available laboratory and diagnostic techniques mainly involve D-dimer test, ultrasound, venography, and magnetic resonance imaging. The latter two diagnostic tools require high doses of contrast agents including either radioactive or toxic materials. The available treatment options include lifestyle modifications, mechanical compression, anticoagulant therapy, inferior vena cava filter, and thrombolysis/thrombolectomy. All of these medical and surgical treatments have serious side effects including improper clot clearance and increased risk of hemorrhage occurrence. Therefore, research in this field has recently focused on the development of non-invasive and accurate diagnostics, such as ultrasound enhanced techniques and molecular imaging methods, to assess thrombus location and its treatment course. The frontier of nanomedicine also shows high prospects in tackling DVT with efficient targeted drug delivery. This review describes the pathology of DVT along with successive medical problems such as PE and features a detailed listing of various diagnostic and therapeutic modalities that have been in use and are under development.

AB - Deep vein thrombosis (DVT) affects up to 2 million people in the United States, and worldwide incidence is 70 to 113 cases per 100,000 per year. Mortality from DVT is often due to subsequent pulmonary embolism (PE). Precise diagnosis and treatment is thereby essential for the management of DVT. DVT is diagnosed by a thorough history and physical examination followed by laboratory and diagnostic tests. The choice of laboratory and diagnostic test is dependent on clinical pretest probability. Available laboratory and diagnostic techniques mainly involve D-dimer test, ultrasound, venography, and magnetic resonance imaging. The latter two diagnostic tools require high doses of contrast agents including either radioactive or toxic materials. The available treatment options include lifestyle modifications, mechanical compression, anticoagulant therapy, inferior vena cava filter, and thrombolysis/thrombolectomy. All of these medical and surgical treatments have serious side effects including improper clot clearance and increased risk of hemorrhage occurrence. Therefore, research in this field has recently focused on the development of non-invasive and accurate diagnostics, such as ultrasound enhanced techniques and molecular imaging methods, to assess thrombus location and its treatment course. The frontier of nanomedicine also shows high prospects in tackling DVT with efficient targeted drug delivery. This review describes the pathology of DVT along with successive medical problems such as PE and features a detailed listing of various diagnostic and therapeutic modalities that have been in use and are under development.

KW - Embolism

KW - Fibrin clot

KW - Nanoparticles

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84879412201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879412201&partnerID=8YFLogxK

U2 - 10.1016/j.biotechadv.2012.08.004

DO - 10.1016/j.biotechadv.2012.08.004

M3 - Article

C2 - 22940402

AN - SCOPUS:84879412201

VL - 31

SP - 504

EP - 513

JO - Biotechnology Advances

JF - Biotechnology Advances

SN - 0734-9750

IS - 5

ER -